Aurobindo Pharma Ltd :

187.35 -2.70 [-1.42%]

ISIN: INE406A01037 | NSE: AUROPHARMA | Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln | BSE Code: 524804 | Comments

Price Information
• Open	190.00
• High	191.70
• Low	186.10
• Previous Close	190.05
• Shares Traded	107145
• 52 Wk High Price	204.90
• 52 Wk High Date	-
• 52 Wk Low Price	99.65
• 52 Wk Low Date	-
• Face Value	1.00

Fundamentals
• Market Capital (Rs.cr)	5598.32
• EPS (Rs.)(TTM)	14.25
• P/E Ratio(TTM)	13.47
• Book Value (Rs.)	85.60
• Price to Book Value	2.24
• Equity (Rs.cr.)	29.12
• Traded Value (Rs.lac)	282.26

Corporate Actions
Ex-Date	Purpose (Rs.)
2010-11-11	100% Interim Dividend (5)
2011-02-10	Stock Split from Rs.5 to Rs.1 (0)
2011-07-20	100% Final Dividend (1)
2012-07-30	100% Dividend (1)
2013-02-18	100% Interim Dividend (1)

Index Names
• BSE-200
• BSE-500
• BSE HC
• Nifty Midcap 50

Related Companies
Stock Name	Price

CIPLA	418.20
JBCHEPHARM	84.55
JAYANTVITAMINS	3.00	-
MERIND	200.00	-
PIRHEALTH	570.00
RANBAXY	437.75
UNICHEMLAB	182.00
ALEMBICLTD	19.65
LYKALABS	9.26
TTKHEALTH	506.70

Share Tips for Aurobindo Pharma Ltd

Market outlook : After flat open, marke (08:54AM, May 21 '13)

goo.gl/aVfGF free option tips|| buy se (01:14PM, May 13 '13)

auropharma option call tips nifty-opti (12:35PM, May 10 '13)

Buy Auropharma cmp 196.15 (future), s (11:44AM, May 08 '13)

Sell Auropharma cmp 195.45, sl 197, t (12:09PM, May 07 '13)

Mutual funds holding in Aurobindo Pharma Ltd

Sundaram BNP Paribas Select Midcap - Growth

Kotak Opportunities Fund - Growth

Birla Sun Life Mid Cap Fund - Plan A - Growth

Sahara Growth Fund - Growth

Franklin India Prima Plus - Growth

Key Financials	Latest Qrtr.	Trailing Yr.	Full Yr.
• Year End	Dec, 2012	Dec, 2012	Mar, 2012
• Sales (Rs.cr)	1412.63	5046.67	4281.45
• Net Profit (Rs.cr)	144.28	414.92	271.80
• Net Profit Var (%)	999.00	29.00	-56.00
• EPS (Rs)	-	14.25	9.20
• P/E Ratio	-	13.47	20.90
• Operating Profit Margin	-	15.59	-
• CPS (Rs.)	-	-	14.10
• P/C Ratio	-	-	13.70
• Div%	-	-	100.00

Announcements
12-10-2012	Aurobindo Pharma received tentative approval for the Risedronate Sodium tablets
06-08-2012	Aurobindo Pharma receives final approvals for Montelukast Sodium tablets and Chewable tablets
11-02-2012	Aurobindo Pharma adjourns board meeting
30-12-2010	Aurobindo Pharma allots equity shares
19-01-2012	Aurobindo Pharma appoints additional director
22-11-2012	Aurobindo Pharma appoints CEO
03-11-2010	Aurobindo Pharma declares interim dividend
07-09-2011	Aurobindo Pharma establishes a joint venture company with Diod (Russia)
06-12-2011	Aurobindo Pharma gets UK MHRA nod for the Bisoprol Fumarate tablets
25-11-2011	Aurobindo Pharma gets UK MHRA nod for the Cefpodoxime Proxetil tablets
16-12-2011	Aurobindo Pharma grants options
07-09-2012	Aurobindo Pharma received final approval for the Generic Lotrel
21-11-2011	Aurobindo Pharma received final approval for the Lamivudine tablets
18-05-2011	Aurobindo Pharma receives approvals for Risperidone tablets, oral solution & Alendronate tablets fr
16-05-2012	Aurobindo Pharma receives final approval for Lamivudine & Zidovudine tablets
26-04-2012	Aurobindo Pharma receives final approval for Olanzapine Tablets
29-03-2012	Aurobindo Pharma receives final approvals for Quetiapine Fumarate tablets
30-04-2013	Aurobindo Pharma Receives USFDA Approval for Quinapril Tablets
30-05-2012	Aurobindo Pharma recommends final dividend
09-05-2012	Aurobindo Pharma to announce financial results
27-07-2011	Aurobindo Pharma to announce Q1 results
31-10-2011	Aurobindo Pharma to announce Q2 results
25-01-2011	Aurobindo Pharma to announce Q3 results
21-05-2012	Aurobindo Pharma to consider dividend
29-10-2010	Aurobindo Pharma to consider interim dividend
26-11-2010	Aurobindo Pharma to convene EGM
13-08-2012	P L Sanjeev Reddy ceases as director of Aurobindo Pharma

Gross Deliverables

Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover

17-05-2013 52135 146290 35.64 10022954 28225.80
13-05-2013 50671 203507 24.90 9645225 39663.40
11-05-2013 5321 29121 18.27 1036797 5664.21
10-05-2013 53785 294437 18.27 10482697 56754.40
03-05-2013 91478 415998 21.99 17980001 82723.00

Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action

Comment(s) posted on Aurobindo Pharma Ltd

Hot Searches • picca • geod • prism • austr • hanung • krbl • educom • entegra • biocon • siemens

Date	Del. Shares	Trd. Qty.	Del.(%)	Del. Value	Turnover
17-05-2013	52135	146290	35.64	10022954	28225.80
13-05-2013	50671	203507	24.90	9645225	39663.40
11-05-2013	5321	29121	18.27	1036797	5664.21
10-05-2013	53785	294437	18.27	10482697	56754.40
03-05-2013	91478	415998	21.99	17980001	82723.00